Parameter
| Biomarker | GFAP | Full name | Glial Fibrillary Acidic Protein | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Pathological Confirmation |
| Disease | Parkinson's Disease | Disease Subtypes | / | ||
| Organ | Brain | Test Sample / Technology Platform | Plasma/CSF (SIMOA, Immunoassay) | ||
| Pathobiological Mechanisms | A marker of astrocyte activation, responding to α-syn pathology and neuroinflammation | ||||
| Clinical Availability Status | Research validation: Plasma levels in PD patients are 30% higher than those in healthy individuals. | ||||
| Notes and Dynamics | Can predict cognitive decline in PD. | ||||